← Back to Search

Nanoparticle Therapy

AuroShell particle infusion for Prostate Cancer

N/A

Waitlist Available

Research Sponsored by Nanospectra Biosciences, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one year

Awards & highlights

Study Summary

This trial is testing whether using MRI/US fusion imaging to guide focal ablation of prostate tissue using nanoparticle-directed laser irradiation is effective.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evidence of efficacy of focal ablation of clinically significant targeted prostate lesion(s)

Evidence of efficacy of focal ablation of clinically significant targeted prostate lesion(s) confirmed using 3T MRI/Ultrasound guided biopsy 3 months after treatment.

Secondary outcome measures

Adverse Events

Trial Design

1Treatment groups

Experimental Treatment

Group I: AuroShell particle infusionExperimental Treatment1 Intervention

Single intravenous infusion of AuroShell particles 12 to 36 hours prior to MRI/US guided laser irradiation using an FDA cleared laser and an interstitial optical fiber diffuser.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

AuroShell particle infusion

2016

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Nanospectra Biosciences, Inc.Lead Sponsor

3 Previous Clinical Trials

57 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many physical sites are being utilized to oversee this research project?

"Eight institutions are included in this medical investigation, including Duke University School of Medicine (Durham), University of Michigan (Ann Arbor) and Mayo Clinic Urology (Rochester). Additionally, five other sites across the United States will be involved."

Answered by AI

Is recruitment currently underway for this experiment?

"According to clinicaltrials.gov, the current status of this trial is not accepting new enrollees. It was initially posted on 1/30/2020 and updated as recently as 7/18/2022. Although participation in this experiment is currently unavailable, there are 1253 other medical studies eagerly enrolling patients at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

2020. "An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04240639.